Evaluation of lymph node surgery in patients with upper urinary tract carcinoma

Lymphadenectomy in urothelial carcinoma in the renal pelvis/calyces (LURP-study)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN83155790

Enrollment

100

Registered

2015-10-07

Start date

2014-01-01

Completion date

Unknown

Last updated

2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urothelial carcinoma of the upper urinary tract Cancer Urothelial carcinoma of the upper urinary tract

Interventions

At the time the retroperitoneal lymphadenectomy is performed on the participants, the location of the lymph node metastases is recorded. The participants are then monitored for 90 days post-surgery fo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or over 2. Locally advanced high grade urothelial carcinoma in the renal pelvis or upper 2/3 of the ureter (Clinical stage > T1)

Exclusion criteria

Exclusion criteria: Clinical suspicion of non-muscle invasive UUTUC

Design outcomes

Primary

Measure	Time frame
Location of lymph node metastasis measured at retroperitoneal lymphadenectomy during follow up if the patients suffer from lymph node recurrence, within a two year period.	—

Secondary

Measure	Time frame
Post surgical complications are monitored throughout 90 days after surgery, by examining patient charts. After 90 days, a Clavien score between 0 and 5 is determined.	—

Countries

Norway, Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026